Literature DB >> 4003562

Development of myocardial dysfunction in endotoxin shock.

J L Parker, H R Adams.   

Abstract

Isolated heart muscle preparations were used to investigate the onset and development of myocardial inotropic dysfunction during endotoxin shock in guinea pigs. Left atrial muscles were removed from separate groups of animals at increasing time intervals after administration of either 4 mg/kg purified Escherichia coli endotoxin (shock groups) or an equivalent volume of isotonic saline (control groups). Peak developed contractile tension (CT) and maximal rate of tension development (+dT/dtmax) were significantly depressed in shock tissues as early as 2 h postendotoxin (P less than 0.01), with the magnitude of the contractile deficit progressively increasing during 4, 6, and 12 h postendotoxin. Contractility remained significantly depressed (P less than 0.001) at 16 and 24 h postendotoxin but progressively recovered toward control levels during 16, 24, 48, and 72 h postendotoxin. Shock-induced myocardial dysfunction was characterized by altered contractile responsiveness to low-Ca2+ medium (0.5 mM), gentamicin (4 mM), and hypoxia; altered inotropic reactivity to these interventions followed similar temporal development as the postendotoxin changes in basal contractile parameters. Left ventricular papillary muscles obtained at 16 h postendotoxin corroborated the shock-induced contractile depression observed in atria. These studies provide evidence for early and progressive intrinsic myocardial dysfunction in endotoxin shock and demonstrate that this dysfunction can be unmasked through the study of in vitro atrial and ventricular heart muscle preparations isolated from in vivo shocked animals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4003562     DOI: 10.1152/ajpheart.1985.248.6.H818

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes.

Authors:  P V Sulakhe; L Sandirasegarane; J P Davis; X T Vo; W J Costain; R R Mainra
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

3.  Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes.

Authors:  Monica Patten; Sabine Stübe; Bryan Thoma; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

4.  The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.

Authors:  Matthias Behrends; Jürgen Peters
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

5.  Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models.

Authors:  S H Zuckerman; A M Bendele
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  R Schulz; D L Panas; R Catena; S Moncada; P M Olley; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.